TARLATAMAB YA ES EL NUEVO TRATAMIENTO ESTÁNDAR DE SEGUNDA LINEA SMALL CELL LUNG CANCER EXTENSIVE-STAGE ... PARECE EVIDENTE QUE TARLATAMAB PODRÍA SER EL NUEVO PARADIGMA EN TODAS LAS LÍNEAS DE TRATAMIENTO SCLC-ES INCLUIDA LA DE MANTENIMIENTO ... EN LA QUE YA ESTÁ EN PLENA FASE III COMBINADO CON ATEZOLIZUMAB DE ROCHE ... Y ADEMÁS CUENTA CON EL STATUS DE ORPHAN DRUG EN ESTADOS UNIDOS .
24 julio 2019
STAR MARKET , Brillante Estreno del Nuevo Nasdaq Chino . China's answer to the Nasdaq just started trading. One stock soared 500% .
Hong Kong (CNN Business)China has launched its latest bid for tech superpower status by opening a Nasdaq-style stock market in a frenzy of buying by investors that sent share prices soaring.
Trading on the new tech board of the Shanghai stock exchange, known as the Star Market, began on Monday, less than a year after the initiative was unveiled by President Xi Jinping.
The 25 stocks listed on Star gained 160% on average by midday in China. Shares in Anji Microelectronics Technology, which makes materials for semiconductors, rocketed as much as 520% before trimming those gains a little. ...